Literature DB >> 8842043

Species difference in the disposition of liposomes among mice, rats, and rabbits: allometric relationship and species dependent hepatic uptake mechanism.

H Harashima1, S Komatsu, S Kojima, C Yanagi, Y Morioka, M Naito, H Kiwada.   

Abstract

PURPOSE: The species difference in the pharmacokinetics of liposomes was investigated in mice, rats and rabbits.
METHODS: Liposomes were intravenously injected at doses of 1, 10 and 100 (nmol/g body weight), and the time courses of liposomes in blood, liver and spleen were measured. Pharmacokinetic parameters were regressed as a function of body weight (BW) and dose of liposomes (D). The uptake mechanism of liposomes was also examined with the isolated perfused liver between rats and mice.
RESULTS: Mean residence time increased with the increase of BW and D of liposomes. This increase of mean residence time resulted from the decreased total body clearance, which was principally explained by the species difference in the hepatic uptake clearance (CLh) of liposomes. The parameter CLh was regressed well by a multiple regression as a function of BW and D. In this analysis, an exponent for BW was around 0.5, which clearly indicates that smaller animals have higher uptake clearance per unit BW. Immunohistochemical analysis revealed that there was no significant difference in the density of Kupffer cells among these species. This suggest that the species difference in CLh resulted not from the density of Kupffer cells but from the uptake ability of Kupffer cells among species. In the isolated perfused liver, the hepatic uptake of liposomes was mainly explained by opsonin dependent uptake in rats, while opsonin independent uptake in mice.
CONCLUSIONS: These quantitative and qualitative information on the species difference of liposome disposition will provide an useful information for constructing a drug delivery system using liposomes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8842043     DOI: 10.1023/a:1016058724452

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  15 in total

1.  The effect of particle size and charge on the clearance rates of liposomes and liposome encapsulated drugs.

Authors:  R L Juliano; D Stamp
Journal:  Biochem Biophys Res Commun       Date:  1975-04-07       Impact factor: 3.575

2.  Quantitative Relations in the Physiological Constitutions of Mammals.

Authors:  E F Adolph
Journal:  Science       Date:  1949-06-10       Impact factor: 47.728

3.  Nonlinear tissue distribution of ouabain in rabbits.

Authors:  H Harashima; Y Sugiyama; T Iga; M Hanano
Journal:  Drug Metab Dispos       Date:  1988 Jul-Aug       Impact factor: 3.922

4.  Enhanced hepatic uptake of liposomes through complement activation depending on the size of liposomes.

Authors:  H Harashima; K Sakata; K Funato; H Kiwada
Journal:  Pharm Res       Date:  1994-03       Impact factor: 4.200

5.  A pharmacokinetic analysis program (multi) for microcomputer.

Authors:  K Yamaoka; Y Tanigawara; T Nakagawa; T Uno
Journal:  J Pharmacobiodyn       Date:  1981-11

6.  Contribution of complement system on destabilization of liposomes composed of hydrogenated egg phosphatidylcholine in rat fresh plasma.

Authors:  K Funato; R Yoda; H Kiwada
Journal:  Biochim Biophys Acta       Date:  1992-01-31

7.  Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors.

Authors:  A Gabizon; D Papahadjopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

8.  Kinetic analysis of AUC-dependent saturable clearance of liposomes: mathematical description of AUC dependency.

Authors:  H Harashima; C Yamane; Y Kume; H Kiwada
Journal:  J Pharmacokinet Biopharm       Date:  1993-06

9.  Effects of liposome size on the degradation of bovine brain sphingomyelin/cholesterol liposomes in the mouse liver.

Authors:  P L Beaumier; K J Hwang
Journal:  Biochim Biophys Acta       Date:  1983-05-26

10.  Pharmacokinetics of stealth versus conventional liposomes: effect of dose.

Authors:  T M Allen; C Hansen
Journal:  Biochim Biophys Acta       Date:  1991-09-30
View more
  5 in total

Review 1.  Factors influencing the use and interpretation of animal models in the development of parenteral drug delivery systems.

Authors:  Marilyn N Martinez
Journal:  AAPS J       Date:  2011-10-05       Impact factor: 4.009

2.  Dual physiologically based pharmacokinetic model of liposomal and nonliposomal amphotericin B disposition.

Authors:  Leonid Kagan; Pavel Gershkovich; Kishor M Wasan; Donald E Mager
Journal:  Pharm Res       Date:  2013-06-21       Impact factor: 4.200

3.  Long-circulating PEGylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery.

Authors:  P Calvo; B Gouritin; H Chacun; D Desmaële; J D'Angelo; J P Noel; D Georgin; E Fattal; J P Andreux; P Couvreur
Journal:  Pharm Res       Date:  2001-08       Impact factor: 4.200

4.  Pharmacokinetics and urinary excretion of amikacin in low-clearance unilamellar liposomes after a single or repeated intravenous administration in the rhesus monkey.

Authors:  R M Fielding; L Moon-McDermott; R O Lewis; M J Horner
Journal:  Antimicrob Agents Chemother       Date:  1999-03       Impact factor: 5.191

Review 5.  Research tools for extrapolating the disposition and pharmacokinetics of nanomaterials from preclinical animals to humans.

Authors:  Michael S Valic; Gang Zheng
Journal:  Theranostics       Date:  2019-05-18       Impact factor: 11.556

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.